Calcification of advanced atherosclerotic lesions in the innominate arteries of ApoE-deficient mice - Potential role of chondrocyte-like cells

被引:141
作者
Rattazzi, M
Bennett, BJ
Bea, F
Kirk, EA
Ricks, JL
Speer, M
Schwartz, SM
Giachelli, CM
Rosenfeld, ME
机构
[1] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA
[2] Univ Washington, Interdisciplinary Grad Program Nutr Sci, Seattle, WA 98195 USA
[3] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA
[4] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
关键词
atherosclerosis; calcification; chondrocytes; apolipoprotein E-deficient mice;
D O I
10.1161/01.ATV.0000166600.58468.1b
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Advanced atherosclerotic lesions in the innominate arteries of chow-fed apolipoprotein E-deficient mice become highly calcified with 100% frequency by 75 weeks of age. The time course, cell types, and mechanism(s) associated with calcification were investigated. Methods and Results-The deposition of hydroxyapatite is preceded by the formation of fibro-fatty nodules that are populated by cells that morphologically resemble chondrocytes. These cells are spatially associated with small deposits of hydroxyapatite in animals between 45 and 60 weeks of age. Immunocytochemical analyses with antibodies recognizing known chondrocyte proteins show that these cells express the same proteins as chondrocytes within developing bone. Histological and electron microscopic analyses of lesions from animals between 45 and 60 weeks of age show that the chondrocyte-like cells are surrounded by dense connective tissue that stains positive for type II collagen. Nanocrystals of hydroxyapatite can be seen within matrix vesicles derived from the chondrocyte-like cells. In mice between 75 and 104 weeks of age, the lesions have significantly reduced cellularity and contain large calcium deposits. The few remaining chondrocyte-like cells are located adjacent to or within the large areas of calcification. Conclusions-Calcification of advanced lesions in chow-fed apolipoprotein E-deficient mice occurs reproducibly in mice between 45 and 75 weeks of age. The deposition of hydroxyapatite is mediated by chondrocytes, which suggests that the mechanism of calcification may in part recapitulate the process of endochondral bone formation.
引用
收藏
页码:1420 / 1425
页数:6
相关论文
共 39 条
  • [11] OSTEOPONTIN IS ELEVATED DURING NEOINTIMA FORMATION IN RAT ARTERIES AND IS A NOVEL COMPONENT OF HUMAN ATHEROSCLEROTIC PLAQUES
    GIACHELLI, CM
    BAE, N
    ALMEIDA, M
    DENHARDT, DT
    ALPERS, CE
    SCHWARTZ, SM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) : 1686 - 1696
  • [12] Osteopontin: a versatile regulator of inflammation and biomineralization
    Giachelli, CM
    Steitz, S
    [J]. MATRIX BIOLOGY, 2000, 19 (07) : 615 - 622
  • [13] Isolation of calcifiable vesicles from human atherosclerotic aortas
    Hsu, HHT
    Camacho, NP
    [J]. ATHEROSCLEROSIS, 1999, 143 (02) : 353 - 362
  • [14] Expression of parathyroid hormone-related protein in human and experimental atherosclerotic lesions: functional role in arterial intimal thickening
    Ishikawa, M
    Akishita, M
    Kozaki, K
    Toba, K
    Namiki, A
    Yamaguchi, T
    Orimo, H
    Ouchi, Y
    [J]. ATHEROSCLEROSIS, 2000, 152 (01) : 97 - 105
  • [15] Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification
    Jono, S
    Peinado, C
    Giachelli, CM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (26) : 20197 - 20203
  • [16] Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease
    Jono, S
    Ikari, Y
    Shioi, A
    Mori, K
    Miki, T
    Hara, K
    Nishizawa, Y
    [J]. CIRCULATION, 2002, 106 (10) : 1192 - 1194
  • [17] LETHAL SKELETAL DYSPLASIA FROM TARGETED DISRUPTION OF THE PARATHYROID HORMONE-RELATED PEPTIDE GENE
    KARAPLIS, AC
    LUZ, A
    GLOWACKI, J
    BRONSON, RT
    TYBULEWICZ, VLJ
    KRONENBERG, HM
    MULLIGAN, RC
    [J]. GENES & DEVELOPMENT, 1994, 8 (03) : 277 - 289
  • [18] Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease
    Kiechl, S
    Schett, G
    Wenning, G
    Redlich, K
    Oberhollenzer, M
    Mayr, A
    Santer, P
    Smolen, J
    Poewe, W
    Willeit, J
    [J]. CIRCULATION, 2004, 109 (18) : 2175 - 2180
  • [19] Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice
    Matsui, Y
    Rittling, SR
    Okamoto, H
    Inobe, M
    Jia, N
    Shimizu, T
    Akino, M
    Sugawara, T
    Morimoto, J
    Kimura, C
    Kon, S
    Denhardt, D
    Kitabatake, A
    Uede, T
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (06) : 1029 - 1034
  • [20] Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients
    Nitta, K
    Akiba, T
    Uchida, K
    Otsubo, S
    Takei, T
    Yumura, W
    Kabaya, T
    Nihei, H
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (07) : 1886 - 1889